LESLIE CASIAS: Open Payments
NPI 1699085308 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 28 payments from 9 companies in 2025. Trend: 2023 $6,422 · 2024 $21,840 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $473 |
| PFIZER INC. | 3 | $117 |
| Lundbeck LLC | 3 | $87 |
| Lilly USA, LLC | 1 | $60 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Merz Pharmaceuticals, LLC | 1 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| MERZ NORTH AMERICA, INC. | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
Products named: BOTOX, UBRELVY, QULIPTA, NURTEC ODT, VYEPTI, Xeomin, KISUNLA, Symbravo.
Industry payments across WA — which companies pay providers there.
